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thens, Athletes,
nd Arrhythmias:
he Cardiologist’s Dilemma*
yoko Soejima, MD,
illiam G. Stevenson, MD, FACC
oston, Massachusetts
n 490 BC, the first battle for democracy was fought at the
reek village of Marathon. Though overwhelmingly out-
umbered by an invading Persian horde, the citizen-soldiers
f Athens were victorious. After running 26 miles to Athens
o deliver the stunning news, the Athenian professional
essenger Phidippides collapsed and died. Unfortunately,
he tragedy of unexpected, sudden death in athletes has been
epeated many times; Hank Gathers, Sergei Grinkov, and
lorence Joyner are recent victims.
See page 1053
Corrado et al. (1) estimated the incidence of sudden
eath in athletes from 12 to 35 years of age to be 2.3 per
00,000 athletes/year, compared with 0.9 per 100,000
on-athletes/year in the Veneto region of Italy. Van Camp
t al. (2) estimated the prevalence of sudden death in high
chool and college athletes in the U.S. to be 0.4 per 100,000
thletes per year. The majority of sudden deaths in athletes
re associated with structural heart disease. Maron et al. (3)
eviewed clinical and autopsy data from 158 young athletes
median age 17 years, range 12 to 40 years) who died
uddenly. A cardiovascular cause of death was identified in
34 (85%). Structural heart disease was present in 129
thletes. Hypertrophic cardiomyopathy (36%) and anoma-
ous coronary artery origin (11%) were the most common
ardiac abnormalities identified. An additional 10% of
ictims had an unexplained increase in cardiac mass (possi-
le hypertrophic cardiomyopathy), suggesting that the fre-
uency of hypertrophic cardiomyopathy may be even
reater. When structural heart disease is absent at autopsy,
n abnormality of cardiac ion channels, such as the long-QT
yndrome, or subtle structural abnormality, such as the
olff-Parkinson-White (WPW) syndrome, are potential
auses. The relative importance of causes of sudden death in
thletes may vary in different populations. In the Veneto
rea of Italy, arrhythmogenic right ventricular (RV) cardio-
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Brigham and Women’s Hospital, Harvard Medical School, Boston,
oassachusetts.yopathy is found in 22% of athletes who die suddenly;
ypertrophic cardiomyopathy is found in 2% (4). The
resence of heart disease often escapes detection in the
symptomatic young athlete. Of the 134 victims with
ardiovascular cause of sudden death reported by Maron et
l. (3), 115 had a pre-participation medical evaluation, only
were suspected of having cardiovascular disease, and the
ardiovascular abnormality responsible for sudden death was
orrectly identified in only 1.
Recognition of heart disease, and particularly hypertro-
hic cardiomyopathy, in athletes can be particularly difficult.
s a physiologic adaptation to exercise, the athlete’s heart
nlarges, increasing in mass and left ventricular (LV) cavity
imension (5). In a small proportion of trained adult
thletes, the magnitude of the wall thickness is comparable
o that in mild morphologic expressions of hypertrophic
ardiomyopathy. Between 1% and 2% of athletes have an
V wall thickness of 13 to 16 mm. Several studies have
valuated methods to differentiate between hypertrophic
ardiomyopathy and physiologic hypertrophy of the ath-
ete’s heart (6,7). A small LV cavity dimension, enlarged left
trial diameter, abnormal diastolic filling pattern, pathologic
waves, and ST-T abnormalities on the electrocardiogram
ECG) favor hypertrophic cardiomyopathy, whereas a peak
xygen consumption 50 ml/kg/min or 20% suggests a
raining effect most likely to produce physiologic hypertro-
hy. Asymmetrical hypertrophy or failure of hypertrophy to
iminish with the cessation of regular exercise suggests
ypertrophic cardiomyopathy (5). Physiologic hypertrophy
n the athlete’s heart is symmetric and reversible with
econditioning. Pelliccia et al. (8) observed that during
ong-term (1 to 13 years; mean 5.6  3.8 years) decondi-
ioning LV cavity dimension decreased by 7%, maximum
all thickness diminished by 15%, and ventricular mass
normalized to height) decreased by 28%. In all of these
thletes, wall thickness returned to the normal, but 22%
thletes showed persistent chamber dilation (60 mm).
Arrhythmias can be a marker for heart disease and
enerate appropriate concern when discovered in athletes.
n a previous report by Biffi et al. (9), a total of 355 of
5,889 athletes had 3 premature ventricular contractions
PVCs) on 12-lead ECG (n  337) or a history of
alpitations (n  18) and underwent further evaluation.
verall, only 7% of these athletes harbored structural
ardiovascular abnormalities. Structural heart disease was 15
imes more frequent in athletes with frequent and complex
entricular tachycardias (VTs) than in those with less severe
rrhythmias. The 71 patients with 2,000 PVCs/24 h were
estricted from participating in competitive sports. Over the
ight-year follow-up period, the risk of sudden death proved
o be exceedingly low. One patient who had arrhythmogenic
V dysplasia died suddenly while playing hockey against
edical advice. No sudden cardiac deaths occurred in the
thletes who had frequent and complex arrhythmias but no
ther cardiovascular abnormalities. Annual mortality was
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Editorial Comment September 1, 2004:1059–61.17%. Although these data suggest that some of these
thletes may not require restriction from competitive ath-
etics, whether the outcome would have been as favorable if
hey continued competitive athletics is not known.
Are frequent arrhythmias in and of themselves a sufficient
eason to restrict physical activity? How can those that are a
arker for heart disease and sudden death risk be distin-
uished from benign arrhythmias? In this issue of the
ournal, Biffi et al. (10) extend their previous study. Specif-
cally, they assess the impact of deconditioning on ventric-
lar arrhythmias in their previously identified population of
thletes and correlate those findings with presence of heart
isease in a manner similar to that suggested to distinguish
hysiologic from pathologic hypertrophy in athletes. Of the
55 athletes with 3 PVCs on 12-lead ECG (n  337) or
istory of palpitation (n  18), 70 had 2,000 PVCs/24 h
nd/or  burst of nonsustained VT on ambulatory ECG
ecording. The one patient who died suddenly while playing
eld hockey was excluded. The remaining 70 athletes
nderwent a deconditioning period of at least 3 months.
fter deconditioning, a second 24-h recording demon-
trated a reduction in arrhythmia for the group overall.
otal PVC frequency decreased by 80%, couplets decreased
y 80%, and the number of nonsustained VT episodes
ecreased by 90%. Fifty athletes (71%) showed partial
eduction of arrhythmia (PVCs decreased to500/24 h and
bsence of nonsustained VT) or complete absence of ven-
ricular arrhythmias.
Reversibility of arrhythmia with deconditioning did not,
owever, always indicate absence of structural heart disease.
lthough 74% of patients who had a decrease in ectopy had
o cardiovascular abnormalities, heart disease was present in
6%, including mitral valve prolapse (n  5), myocarditis
n  3), dilated cardiomyopathy (n  3), and arrhythmo-
enic RV cardiomyopathy. In the 29% of the athletes for
hom no change of frequency was observed after decondi-
ioning; 13 (65%) had no cardiovascular abnormalities; the
emaining 35% had disease including arrhythmogenic RV
ardiomyopathy (n  4), mitral valve prolapse (n  1),
yocarditis (n  1), or dilated cardiomyopathy (n  1).
he decrease in LV mass after detraining did not differ
etween athletes who had reversibility of arrhythmias com-
ared to those with no change. Of 24 athletes who under-
ent electrophysiology study, only one had inducible sus-
ained VT. During the 8  4 years follow up, all 70 athletes
urvived without cardiac arrests. The 37 athletes with no
tructural heart disease and partial or complete reduction of
mbient arrhythmia after deconditioning resumed compet-
tive sports without restriction, as did six athletes who had
ardiovascular abnormalities but who had a reduction in
rrhythmias with detraining. No sudden deaths occurred in
hese individuals during the remaining follow-up time.
There are important caveats. Only two 24-h Holter
ecordings were obtained. Although the authors report that
control group composed of subjects with less frequent
rrhythmia had similar severity of arrhythmia on twoecordings, ambient ventricular ectopy often displays sub-
tantial day-to-day variability. Fluctuations of 60% in
otal PVCs are not uncommon (11). Detraining itself would
resumably alter the subjects’ activity level during the two
ecording periods, because the workout during the second
ecording would presumably be less strenuous than before
etraining. A decrease in frequency of ectopy may not,
herefore, reflect changes in cardiac electrophysiologic prop-
rties. It is possible that those subjects who had a decrease
n ectopy at the second study simply had greater spontane-
us variability than those with similar severity of ectopy at
oth studies. The QRS morphology of the arrhythmia was
ot assessed and could be helpful in assessing presence of a
tructural abnormality. Idiopathic PVCs often originate
rom the RV outflow tract and have a characteristic left
undle branch block and inferior-axis QRS morphology.
rrhythmogenic RV cardiomyopathy can also, however,
ause this morphology. Thus, it cannot be established with
ertainty whether the ventricular arrhythmias in athletes
ithout heart disease were specifically related to a training
ffect, perhaps associated with hypertrophy, or simply be-
ign idiopathic arrhythmia such as RV outflow tract ven-
ricular ectopy (which can be encountered in sedentary
ndividuals).
What is the approach to evaluation of athletes who are
ound to have ventricular ectopy? First, an underlying
ardiac abnormality is relatively common, and careful eval-
ation is warranted with echocardiography and exercise
tress testing. The ECG should be assessed for markers of
PW, Brugada, and long-QT syndromes, although these
isorders are not usually associated with frequent ambient
ctopy. Although not addressed in the present study, a
amily history of sudden death should be sought and, if
resent, would warrant more extensive evaluation for ge-
etic disorders, potentially including electrophysiologic
tudy. Patients with structural heart disease, in particular
ypertrophic, dilated, or RV cardiomyopathies, should be
estricted from competitive athletics, following current ac-
epted guidelines (12). In the absence of structural heart
isease or markers of these other arrhythmogenic syn-
romes, the risk of sudden death is likely quite low. A
ecrease in ventricular arrhythmias produced by detraining
ay further support the safety of allowing a return to
thletics. It should be recognized, however, that a favorable
ecrease in arrhythmia frequency does not exclude the
ossibility of underlying heart disease and that substantial
pontaneous variability in arrhythmia frequency is common.
careful cardiac evaluation and case-by-case assessment is
equired.
eprint requests and correspondence: Dr. Kyoko Soejima, Car-
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